EP-1546: Outcomes of monotherapeutic permanent brachytherapy for apanese localized prostate cancer
Norihisa Katayama(Okayama University), S. Kanazawa(National Hospital Organization), Yasutomo Nasu(Okayama University), Atsushi Takamoto(Okayama University), Hideyuki Ihara(Okayama University), Kaori Watanabe, Mitsuhiro Takemoto(Okayama University), Hiroki Okawa, Yoko Oiwa, Kuniaki Katsui(Fukuyama City Hospital)
Cited by 0
Related Papers
Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles
|Cancer Research|2007|206
Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
|Molecular and Clinical Oncology|2016|79
Analysis of Factors Associated With Radiation-Induced Bronchiolitis Obliterans Organizing Pneumonia Syndrome After Breast-Conserving Therapy
|International Journal of Radiation Oncology*Biology*Physics|2008|69
Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways
|Oncogene|2009|48
Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma
|The Journal of Urology|2020|44